Biography

Biotech Avenir

Biotech Avenir SAS is a management holding company incorporated in 2001 by the Company's founders. Most of its share capital is currently held by individuals, i.e. the co-founders of the Company and twelve Company employees. Jean-François Mouney, the Chairman of the Board of Directors of the Company, is also the Chairman of the Management Committee of Biotech Avenir SAS.

As of April 1, 2024, Biotech Avenir SAS held 3.79% of the share capital of the Company.

Florence Séjourné

Florence Séjourné, as member of the Management Committee of Biotech Avenir, represents Biotech Avenir in the Board of Directors of the Company.

Florence Séjourné is the CEO of AUROBAC THERAPEUTICS, a biopharmaceutical company dedicated to the fight against severe bacterial infections and their consequences in acute hospital settings.

Prior to this role, Florence served as CEO of DA VOLTERRA. She co-founded GENFIT with Jean-François Mouney and Pr. Bart Staels and spent 9 years working at GENFIT where she held the position of Chief Operating Officer. In 2008, she became a member of the Supervisory Board.

In 2015, Florence founded the BEAM Alliance, an association representing over 70 European biotech companies developing innovative solutions against AMR where she is currently Board member.

Florence holds engineering and pharmaceutical sciences degrees from Mines Paris - PSL and the University of Illinois at Chicago.